Phase 1 study of intravenous rigosertib (ON 01910.Na), a novel benzyl styryl sulfone structure producing G2/M arrest and apoptosis, in adult patients with advanced cancer.
AMERICAN JOURNAL OF CANCER RESEARCH（2013）
Key words
Rigosertib,ON01910.Na,phase 1 study,polo-like kinase,phosphatidylinositol-3-kinase
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined